I keep a written log of every draw with date, volume and syringe type.
I am at the decision point and I would rather think it through than improvise.
I would rather spend money on measurement than on redundancy.
What is the minimum version of this that is still defensible?
Answer first: inspect before you reconstitute, because after reconstitution you cannot distinguish a particle that arrived with the powder from one you introduced.
Weigh the vial if you have a scale reading to a milligram. It will not give you content, but a vial several tens of milligrams lighter than its siblings is a fill problem.
| Configuration | Dead volume | Loss at 5 mg/mL | Over 20 draws |
|---|---|---|---|
| Fixed-needle insulin syringe | 3–5 µL | 15–25 µg | 0.3–0.5 mg |
| Low-dead-space, detachable | <2 µL | <10 µg | <0.2 mg |
| Standard luer-lock + 30G | 35–60 µL | 175–300 µg | 3.5–6 mg |
| Luer-lock + 21G drawing needle | 70–100 µL | 350–500 µg | 7–10 mg |
Confirm the lot code is physically on the vial and legible, and that it matches the certificate and the invoice. A code on the box only ties a certificate to a box.
Visual inspection for particulate matter is a pharmacopoeial requirement for parenteral products and the standard technique uses both light and dark backgrounds.
A vial that passes inspection has passed a very weak test. It has not been verified.
Photograph anything unexpected before touching it further.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemAnswering this needs to know what you are looking for, because most people inspect vials without a list and therefore see nothing.
Look for fibres, glass fragments and dark particulate in the cake. Glass is the one that matters and is usually a crimping or handling artefact rather than a synthesis one.
Check the fill looks proportionate to the label claim. Ten milligrams of peptide is a small volume of powder, but it is not nothing, and a vial that looks empty is worth a photograph.
Nothing here is medical advice, and research-use compounds are not approved for human use.
The lot code has to be on the vial. A code on the box ties nothing to anything.
The short version: intact crimp, seated stopper, legible lot code, and a cake that looks like a cake.
Inspect the powder against both a white and a black background under good light. Discolouration, browning or a yellow tinge on a peptide that should be white is worth photographing before doing anything else.
The part that matters: after reconstitution, hold against a light and look for haze, floaters or a Tyndall effect. A clear solution that goes clear on contact is what a well-made preparation looks like.
Lot traceability to the primary container rather than to secondary packaging is a basic requirement of any documentation system worth the name.
Inspect before reconstitution. Afterwards you cannot tell whose particle it is.
edited 7 Oct 2024 by Dr_Ingrid_Baumgartner — tightened the wording; no substantive change
Start with the seal, the stopper and the label, in that order, and then look at the contents against a light and a dark background.
Check the aluminium crimp is fully seated with no lift at the edge, the flip-off cap has not been previously removed, and the stopper sits flush without a visible gap or dimple.
The caveat is that inspection cannot detect identity, purity, content or endotoxin, which are the things most likely to be wrong.
Crimp, stopper, label, contents. Light background and dark background.
edited 7 Sept 2024 by tamsin_wray — updated for the 2026 guidance change
The honest answer is that most defects found are cosmetic and the few that are not are obvious once you know the list.
Melt-back at the stopper — a glassy ring where the cake meets the closure — indicates the cycle ran warm at the top of the vial. Cosmetic in most cases, informative always.
Melt-back and collapse are documented lyophilisation cycle defects with well-described visual appearances.
Do not open a vial you intend to return or claim on; photograph it sealed first.
Passing inspection is a weak result. It rules out the obvious and nothing else.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.